CheckMate -73L trial - Business-News-Today.com

Business-News-Today.com

Business news, market intelligence, and global industry analysis.

Business-News-Today.com

The Latest

What the latest UTOPIA trial data reveal about UGN-103’s competitive position in LG-IR-NMIBC

Delivery Hero (DHER) stock up 4% to €29.5 as Aspex forces CEO exit and Korea sale opens

What the RIDGE-1 interim results reveal about the future of cardiac gene therapy in ARVC

Hanwha Aerospace targets NATO demand with Romania unmanned systems push at BSDA 2026

Read More

Pharma Industry News

Setback for Bristol Myers Squibb: CheckMate -73L trial fails to meet endpoint

Bristol Myers Squibb (NYSE: BMY) announced that its Phase 3 CheckMate -73L trial did not achieve its primary…

byPallavi Madhiraju

May 12, 2024

web analytics